Sytrinol® Softgel Highlights

Sytrinol® is a patented blend consisting of citrus extracts and Malaysian red palm oil that contain polymethoxylated flavones (PMFs) and tocotrienols. It promotes cardiovascular health and supports healthy cholesterol levels.

In a clinical trial, softgels manufactured by Soft Gel Technologies, Inc.® exhibited enhanced bioavailability of the key active ingredients found in Sytrinol® — specifically, the two PMFs tangeretin and nobiletin. Compared to powder-filled hard shell capsules, the softgel form of Sytrinol® was significantly more bioavailable in healthy adults.

Sytrinol® has been tested for safety and has been granted self-affirmed GRAS status. The effective dose is just 300mg Sytrinol® daily—the amount found in two easy to swallow Sytrinol® softgels.

  • 100% Natural. Sytrinol® is made from citrus PMFs from immature citrus fruit and peels and tocotrienols (isomers of vitamin E) derived from sustainably sourced virgin red Malaysian palm oil.
  • Clinically effective. Sytrinol® has been shown to be effective at maintaining cholesterol and triglyceride levels already within a normal range in three clinical trials.
  • Not diet-specific. Sytrinol® works on cholesterol production within cells, not on dietary cholesterol.
  • Bioavailable. A bioavailability study found that the citrus PMFs in Sytrinol® are significantly more bioavailable when taken in softgels versus hard shell capsules.
  • Patent-protected. Sytrinol® is protected by the following patents: US Patent Nos. 6,239,114; 6,251,400; 6,987,125; 7,683,095; and 6,184,246.

These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.

is the exclusive raw material supplier of Sytrinol®.
Soft Gel Technologies® is the exclusive manufacturer of Sytrinol® softgels.